Biomedical engineers at Duke University have developed an artificial intelligence platform that can design short proteins capable of binding to and destroying previously untreatable disease-causing proteins. The breakthrough could revolutionise drug development for currently intractable diseases.
MIT and Novo Nordisk researchers have developed an ingestible capsule system that could enable oral delivery of medications typically requiring injection, such as insulin and therapeutic proteins. The needle-free device uses a biomimetic jet propulsion mechanism inspired by cephalopod physiology.
A study from Children’s Hospital of Philadelphia has uncovered rare but severe neurological side effects in children, adolescents, and young adults receiving CAR-T cell therapy for leukaemia, highlighting the need for further investigation into the complex mechanisms underlying these complications.
A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.
Cambridge scientists question whether recently approved amyloid immunotherapy treatments for Alzheimer’s disease will significantly reduce the condition’s burden, citing concerns about efficacy, safety, and health system challenges.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
